BridgeBio Pharma approved equity grants for new employees, vesting quarterly starting May 16, 2026

From GlobeNewswire: 2025-04-11 16:01:00

BridgeBio Pharma, Inc. approved equity grants of 77,652 shares to 20 new employees on April 9, 2025. Vesting of shares will begin on May 16, 2026, with quarterly vesting thereafter, contingent on continued employment. The awards were granted under the 2019 Inducement Equity Plan. These inducements were deemed necessary for new employee recruitment and were granted in accordance with Nasdaq rules. BridgeBio is a biopharmaceutical company focused on genetic diseases, with a pipeline ranging from early science to advanced clinical trials. For more information, visit their website or follow them on social media. Contact Bubba Murarka for further inquiries.



Read more at GlobeNewswire: BridgeBio Pharma Reports Inducement Grants under Nasdaq